India's No.1 PU & Degree With Integrated IAS & IPS(UPSC/PSC) Training College.
ALZHEIMER’S BLOOD TEST AIDS EARLY DETECTION BUT LIMITATIONS Why in the News? A blood test for Alzheimer’s disease biomarkers, already cleared in the U.S. and available in India, can detect biological changes linked to the disease. However, experts caution that it is not a general screening test, particularly for people without symptoms. Science Behind Alzheimer’s …
Read MoreH1N1 Dominates Influenza A Cases Across India Why in the News ? The Indian Council of Medical Research (ICMR) has reported that H1N1 constitutes nearly 98% of Influenza A infections currently detected in India. The ICMR has also clarified that the circulating strain is the familiar H1N1 pdm09 seasonal virus. Current Influenza Situation in India: …
Read MoreCAR-T CELL THERAPY BREAKTHROUGH IN SOLID TUMOURS Why in the News? Scientists have developed a highly sensitive receptor (HIT receptor) that enables CAR-T cells to detect low-level tumour proteins. The breakthrough could make CAR-T therapy effective against solid cancers like kidney and ovarian cancer, overcoming a long-standing limitation. Key scientific advancement Concept innovation: Uses an …
Read MoreIndia Achieves 21% Decline in Tuberculosis Cases Why in the News ? According to the World Health Organization’s Global TB Report 2025, India recorded a 21% decline in tuberculosis (TB) cases over the last decade — nearly double the global average reduction — showcasing the success of national TB elimination initiatives and improved healthcare coverage. …
Read MoreWhy in the News ? Scientists from Tata Memorial Centre have developed patient-derived organoid and xenograft models to study Signet Ring Cell Carcinoma (SRCC), a rare and aggressive colorectal cancer. This breakthrough could enable targeted therapies and improve treatment outcomes for SRCC patients. New Breakthrough in Rare Colorectal Cancer Research: Scientists have devised advanced methods …
Read MoreWhy in the news? AstraZeneca, known for its COVID-19 vaccine Covishield, withdraws globally due to rare side-effects and surplus availability of updated vaccines. source:reuters Key Points:AstraZeneca Withdraws COVID-19 Vaccine: AstraZeneca, in collaboration with Oxford University, has commenced the global withdrawal of its COVID-19 vaccine. Marketed as ‘Covishield’ in India through a partnership with the Serum …
Read More
